Platelet recovery from aspirin inhibition in vivo; differing patterns under various assay conditions.
نویسندگان
چکیده
The linear return of platelet malondialdhyde (MDA) production after aspirin ingestion as described by Stuart et al.4 has been widely accepted as a nonisotopic method for the determination of platelet survival. However. using assays for platelet prostaglandin production and cyclooxygenase activity. a number of authors2’ ’1 have now reported a 24 to 48-hr delay in recovery after aspirin. This delay has been interpreted as evidence that aspirin inhibits megakaryocyte as well as platelet cyclooxygenase. The discrepancy in these findings has not been explained. We have measured the return of production of MDA and thromboxane B2 (TXB2) by platelets of normal volunteers after a single dose of aspirin using a variety of assay conditions. We find striking differences in the pattern of recovery depending upon the presence of protein in the medium in which the platelets are stimulated. Production of both MDA and TXB2 returns in a linear fashion with time when platelets are washed. resuspended in buffer and stimulated with either NEM or thrombin. A 48-hr lag in recovery is seen when platelets are stimulated in whole
منابع مشابه
In vivo aspirin supplementation inhibits nitric oxide consumption by human platelets.
Antiplatelet therapies improve endothelial function in atherosclerosis, suggesting that platelets regulate vascular nitric oxide (NO) bioactivity in vivo. Herein, washed platelets consumed NO on activation in an aspirin-sensitive manner, and aspirin enhanced platelet NO responses in vitro. To examine whether in vivo aspirin can inhibit platelet NO consumption, a double-blind placebo-controlled ...
متن کاملApplication of ex vivo flow chamber system for assessment of stent thrombosis.
OBJECTIVE Factors influencing platelet accumulation around stents were to be investigated by an ex vivo flow chamber system. METHODS AND RESULTS Platelet accumulations on collagen surfaces under flow conditions were augmented in the presence of stents, especially at sites downstream from coil stents. Densitometric analysis revealed that 4.9+/-0.8 times more platelets accumulated downstream fr...
متن کاملSelective and rapid monitoring of dual platelet inhibition by aspirin and P2Y12 antagonists by using multiple electrode aggregometry
BACKGROUND Poor platelet inhibition by aspirin or clopidogrel has been associated with adverse outcomes in patients with cardiovascular diseases. A reliable and facile assay to measure platelet inhibition after treatment with aspirin and a P2Y12 antagonist is lacking. Multiple electrode aggregometry (MEA), which is being increasingly used in clinical studies, is sensitive to platelet inhibition...
متن کاملImpact of Aspirin and Clopidogrel Interruption on Platelet Function in Patients Undergoing Major Vascular Surgery
AIMS To investigate functional platelet recovery after preoperative withdrawal of aspirin and clopidogrel and platelet function 5 days after treatment resumption. METHODS/RESULTS We conducted an observational study, which prospectively included consecutive patients taking aspirin, taking clopidogrel, and untreated controls (15 patients in each group). The antiplatelet drugs were withdrawn fiv...
متن کاملTesting platelet activation with a shear-dependent platelet function test versus aggregation-based tests: relevance for monitoring long-term glycoprotein IIb/IIIa inhibition.
BACKGROUND Tests developed to monitor glycoprotein (GP) IIb/IIIa blockade do not properly reflect platelet function in vivo and need a baseline (pretreatment) value. Because GP IIb/IIIa is essential in platelet aggregation and thrombosis under shear conditions, a flow-dependent approach to monitor its inhibition can be used. METHODS AND RESULTS We compared a test based on flow-dependent plate...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Blood
دوره 57 1 شماره
صفحات -
تاریخ انتشار 1981